Palisade Capital Management LLC Clovis Oncology, Inc. Transaction History

Palisade Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$5.69 - $9.69 $91,040 - $155,040	-16,000 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$3.77 - $11.0 $7,540 - $22,000	2,000 Added 14.29%	16,000 $102,000
Q4 2019 Feb 04, 2020	SELL	$3.0 - $16.43 $12,300 - $67,363	-4,100 Reduced 22.65%	14,000 $146,000
Q3 2019 Nov 06, 2019	BUY	$3.93 - $15.35 $71,133 - $277,835	18,100 New	18,100 $71,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Palisade Capital Management LLC with notifications on news.